These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 18032571)

  • 1. Chronic fenfluramine administration increases plasma serotonin (5-hydroxytryptamine) to nontoxic levels.
    Zolkowska D; Baumann MH; Rothman RB
    J Pharmacol Exp Ther; 2008 Feb; 324(2):791-7. PubMed ID: 18032571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin (5-HT) transporter ligands affect plasma 5-HT in rats.
    Rothman RB; Zolkowska D; Baumann MH
    Ann N Y Acad Sci; 2008 Oct; 1139():268-84. PubMed ID: 18991872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease.
    Zolkowska D; Rothman RB; Baumann MH
    J Pharmacol Exp Ther; 2006 Aug; 318(2):604-10. PubMed ID: 16644904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local perfusion of corticosterone in the rat medial hypothalamus potentiates D-fenfluramine-induced elevations of extracellular 5-HT concentrations.
    Feng N; Telefont M; Kelly KJ; Orchinik M; Forster GL; Renner KJ; Lowry CA
    Horm Behav; 2009 Jun; 56(1):149-57. PubMed ID: 19371745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo effects of d-fenfluramine: no apparent relation between 5-hydroxytryptamine release and hypophagia.
    Raiteri M; Bonanno G; Vallebuona F
    J Pharmacol Exp Ther; 1995 May; 273(2):643-9. PubMed ID: 7752066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain.
    Rothman RB; Jayanthi S; Wang X; Dersch CM; Cadet JL; Prisinzano T; Rice KC; Baumann MH
    Synapse; 2003 Dec; 50(3):233-9. PubMed ID: 14515341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: pharmacokinetic, dose response, regional specificity and time course data.
    Zaczek R; Battaglia G; Culp S; Appel NM; Contrera JF; De Souza EB
    J Pharmacol Exp Ther; 1990 Apr; 253(1):104-12. PubMed ID: 2329498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine prevents the disruptive effects of fenfluramine on differential-reinforcement-of-low-rate 72-second schedule performance.
    Richards JB; Sabol KE; Seiden LS
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1256-63. PubMed ID: 8263788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a role of transporter-mediated currents in the depletion of brain serotonin induced by serotonin transporter substrates.
    Baumann MH; Bulling S; Benaderet TS; Saha K; Ayestas MA; Partilla JS; Ali SF; Stockner T; Rothman RB; Sandtner W; Sitte HH
    Neuropsychopharmacology; 2014 May; 39(6):1355-65. PubMed ID: 24287719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo correlates of central serotonin function after high-dose fenfluramine administration.
    Baumann MH; Ayestas MA; Rothman RB
    Ann N Y Acad Sci; 1998 May; 844():138-52. PubMed ID: 9668672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous effects of p-chloroamphetamine, d-fenfluramine, and reserpine on free and stored 5-hydroxytryptamine in brain and blood.
    Martín F; Artigas F
    J Neurochem; 1992 Sep; 59(3):1138-44. PubMed ID: 1379630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of intravenous microdialysis to monitor changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects of granisetron and ondansetron.
    Castejon AM; Paez X; Hernandez L; Cubeddu LX
    J Pharmacol Exp Ther; 1999 Dec; 291(3):960-6. PubMed ID: 10565811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin release in the caudal nidopallium of adult laying hens genetically selected for high and low feather pecking behavior: an in vivo microdialysis study.
    Kops MS; Kjaer JB; Güntürkün O; Westphal KG; Korte-Bouws GA; Olivier B; Bolhuis JE; Korte SM
    Behav Brain Res; 2014 Jul; 268():81-7. PubMed ID: 24720936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of destruction of serotonin neurons on basal and fenfluramine-induced serotonin release in striatum.
    Kirby LG; Kreiss DS; Singh A; Lucki I
    Synapse; 1995 Jun; 20(2):99-105. PubMed ID: 7570349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fenfluramine metabolite (+)-norfenfluramine is vasoactive.
    Ni W; Li MW; Thakali K; Fink GD; Watts SW
    J Pharmacol Exp Ther; 2004 May; 309(2):845-52. PubMed ID: 14752059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p-Chloroamphetamine- and d-fenfluramine-induced brain serotonin release in experimental portal-systemic encephalopathy.
    Bergqvist PB; Hjorth S; Wikell C; Apelqvist G; Bengtsson F
    Metab Brain Dis; 1997 Sep; 12(3):229-36. PubMed ID: 9346471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of D-fenfluramine on serotonin release in brains of anaesthetized rats.
    Laferrere B; Wurtman RJ
    Brain Res; 1989 Dec; 504(2):258-63. PubMed ID: 2480833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fluoxetine or D-fenfluramine on serotonin release from, and levels in, rat frontal cortex.
    Sarkissian CF; Wurtman RJ; Morse AN; Gleason R
    Brain Res; 1990 Oct; 529(1-2):294-301. PubMed ID: 1704283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phentermine and fenfluramine. Preclinical studies in animal models of cocaine addiction.
    Rothman RB; Elmer GI; Shippenberg TS; Rea W; Baumann MH
    Ann N Y Acad Sci; 1998 May; 844():59-74. PubMed ID: 9668665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine.
    Fitzgerald LW; Burn TC; Brown BS; Patterson JP; Corjay MH; Valentine PA; Sun JH; Link JR; Abbaszade I; Hollis JM; Largent BL; Hartig PR; Hollis GF; Meunier PC; Robichaud AJ; Robertson DW
    Mol Pharmacol; 2000 Jan; 57(1):75-81. PubMed ID: 10617681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.